142 related articles for article (PubMed ID: 11179380)
1. Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.
Boyce JD; Adler B
Infect Immun; 2001 Mar; 69(3):1943-6. PubMed ID: 11179380
[TBL] [Abstract][Full Text] [Related]
2. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
Chung JY; Wilkie I; Boyce JD; Adler B
Vaccine; 2005 Apr; 23(21):2751-5. PubMed ID: 15780722
[TBL] [Abstract][Full Text] [Related]
3. The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).
Boyce JD; Adler B
Infect Immun; 2000 Jun; 68(6):3463-8. PubMed ID: 10816499
[TBL] [Abstract][Full Text] [Related]
4. Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A.
Chung JY; Wilkie I; Boyce JD; Townsend KM; Frost AJ; Ghoddusi M; Adler B
Infect Immun; 2001 Apr; 69(4):2487-92. PubMed ID: 11254611
[TBL] [Abstract][Full Text] [Related]
5. Immunity and vaccine development in Pasteurella multocida infections.
Adler B; Chancellor R; Homchampa P; Hunt M; Ruffolo C; Strugnell R; Wapling D
J Biotechnol; 1996 Jan; 44(1-3):139-44. PubMed ID: 8717397
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane protein H for protective immunity against Pasteurella multocida.
Lee J; Kim YB; Kwon M
J Microbiol; 2007 Apr; 45(2):179-84. PubMed ID: 17483806
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a protective antigen, PlpB of bovine Pasteurella multocida strain LZ-PM.
Wei X; Wang Y; Luo R; Qian W; Sizhu S; Zhou H
Dev Comp Immunol; 2017 Jun; 71():1-7. PubMed ID: 28119019
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a 39kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies.
Ali HA; Sawada T; Hatakeyama H; Ohtsuki N; Itoh O
Vet Microbiol; 2004 May; 100(1-2):43-53. PubMed ID: 15135512
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice.
Dabo SM; Confer A; Montelongo M; York P; Wyckoff JH
Vaccine; 2008 Aug; 26(34):4345-51. PubMed ID: 18598730
[TBL] [Abstract][Full Text] [Related]
10. Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice.
Okay S; Ozcengiz E; Ozcengiz G
Acta Microbiol Immunol Hung; 2012 Dec; 59(4):485-98. PubMed ID: 23195557
[TBL] [Abstract][Full Text] [Related]
11. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).
Wu JR; Shien JH; Shieh HK; Chen CF; Chang PC
Vaccine; 2007 May; 25(21):4140-8. PubMed ID: 17449151
[TBL] [Abstract][Full Text] [Related]
12. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida.
Homchampa P; Strugnell RA; Adler B
Vaccine; 1997 Feb; 15(2):203-8. PubMed ID: 9066039
[TBL] [Abstract][Full Text] [Related]
13. Protection against fowl cholera conferred by vaccination with recombinant Pasteurella multocida filamentous hemagglutinin peptides.
Tatum FM; Tabatabai LB; Briggs RE
Avian Dis; 2009 Jun; 53(2):169-74. PubMed ID: 19630220
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of purified lipopolysaccharide or protein-oligosaccharide conjugates of Pasteurella multocida type 6:B in mice.
Muniandy N; Love DN; Mukkur TK
Comp Immunol Microbiol Infect Dis; 1998 Oct; 21(4):257-79. PubMed ID: 9775357
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
Harper M; John M; Edmunds M; Wright A; Ford M; Turni C; Blackall PJ; Cox A; Adler B; Boyce JD
Vaccine; 2016 Mar; 34(14):1696-703. PubMed ID: 26892738
[TBL] [Abstract][Full Text] [Related]
16. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
Kim TJ; Lee JI; Lee BJ
J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
[TBL] [Abstract][Full Text] [Related]
17. Heterologous protective immunization elicited in mice by Pasteurella multocida fur ompH.
Garrido ME; Bosch M; Bigas A; Badiola I; Barbé J; Llagostera M
Int Microbiol; 2008 Mar; 11(1):17-24. PubMed ID: 18683628
[TBL] [Abstract][Full Text] [Related]
18. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
Seo J; Lee S; Pyo H; Lee J; Kim T
Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida.
Shivachandra SB; Kumar A; Yogisharadhya R; Viswas KN
Vaccine; 2014 Jan; 32(2):290-6. PubMed ID: 24280281
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immune response and efficacy in chickens of vaccines prepared from P. multocida capsular type A grown in iron-depleted conditions.
Gunawardana GA; Frost AJ; Wilkie I
Br Poult Sci; 2004 Apr; 45 Suppl 1():S18-9. PubMed ID: 15222344
[No Abstract] [Full Text] [Related]
[Next] [New Search]